BioHorizons Adds Prolifica Allogeneic Growth Factor to Biomaterials Portfolio - Summary - DentalSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

BioHorizons Adds Prolifica Allogeneic Growth Factor to Biomaterials Portfolio

New option uses biphasic protein release to support bone healing and tissue regeneration.

  • By

  • News Staff

  • August 26, 2026

Share

Objective:

To introduce Prolifica™, an allogeneic growth factor for bone healing and tissue regeneration.

Approach:
  • Product Description: Prolifica contains a blend of allogeneic growth factors and preserves a biphasic release of proteins.
  • Mechanism: It provides an initial release of proteins to support healing, followed by prolonged release for continued support.
  • Protein Composition: Prolifica retains a minimum of 16 proteins related to cell growth, division, bone healing, and tissue regeneration.
  • Application: It can be used in standalone bone grafting or in combination with autologous or allograft bone.
Key Findings:
  • Prolifica supports complex hard tissue regenerative procedures.
  • The product is designed to maintain a high concentration of growth factors.
Interpretation:

Prolifica is positioned as an advanced solution for surgeons dealing with bone grafting in aging populations.

Conclusion:

Prolifica aims to enhance outcomes in bone healing and tissue regeneration.

Sources:

Original Source(s)

BioHorizons Adds Prolifica Allogeneic Growth Factor to Biomaterials Portfolio

  • by News Staff

  • August 26, 2026

Related Content

A Locally Executable AI System for Improving Preoperative Patient Communication: Multidomain Clinical Evaluation

Premier Dental Products to Distribute PerioStōm® for Post-Procedural Periodontal Care

An FDA-cleared, non-drug oral wound dressing, PerioStōm is designed to support gingival healing and patient comfort.

Periapical abscess precipitating diabetic ketoacidosis and reversible sepsis-induced cardiomyopathy: a case report